Relaying what matters next.

Washington just moved to speed new plants and power lines as AI-driven demand surges. New data shows Texas and California pulling ahead in clean power. Here is how the load is shifting, who pays, who profits, and what 2026 to 2030 could look like.

On June 25, 2025, JWST’s MIRI coronagraph delivered Webb’s first direct-image discovery of a new exoplanet: TWA 7b, a Saturn-mass world embedded in its star’s rings. Here is how mid infrared dropped the imaging mass floor and what Roman and HWO will do next.

Google just put Gemini inside Chrome for U.S. desktop users, shifting the browser from passive window to active helper that can read tabs, summarize, and assist tasks. With Anthropic’s Claude-in-Chrome preview and OpenAI’s ChatGPT Agent, the agent wars now move into the address bar.

Israel says Iron Beam will enter service in 2025 after completing operational testing on September 17, 2025. Here is how lasers reshape costs, doctrine, and countermeasures in a layered shield with Iron Dome.

In 48 hours the SEC approved generic listing standards for spot commodity ETPs and permitted in-kind creations. The combo unlocks multi-asset and altcoin ETFs, tighter spreads, and deeper price discovery heading into Q4 2025.

Brussels is moving to halt Russian LNG on January 1, 2027, just as Washington restarts LNG approvals. We pressure test construction, pipelines, ships, methane rules, and financing to see whether new US supply can fill Europe’s gap without spiking prices at home.

Fresh signals from EASD 2025 and a large Medicare analysis suggest GLP-1 therapies cut near-term cardiovascular events and deaths. With potent oral versions on the way, adherence and access could surge, reshaping budgets and the definition of a longevity therapy.

Fresh analyses of Chang'e 6 show the Moon's far side is drier and chemically distinct, with volcanism that persisted for billions of years and a magnetic field that briefly revived. Here is how that reshapes water hunts and south pole site selection for Artemis and ILRS.

Google is rolling out Gemini directly inside Chrome for U.S. users, bringing AI Mode to the address bar, cross-tab summarization, and the first wave of agentic automation. Here is how that reshapes search, SEO, commerce, safety, and the browser’s role.

The Air Force’s first Collaborative Combat Aircraft are moving from hangars to the sky. Here is how first flights reshape tactics and force design, what industry must scale, and which tests and policies unlock FY26 production.

In 2025, the first human data for in vivo PCSK9 base editing showed large, durable LDL-C drops after a single infusion. If safety holds and access follows, one-and-done edits could shift heart disease prevention from chronic care to permanent risk cut.

In March 2025, Firefly’s Blue Ghost stuck a clean touchdown at Mare Crisium, while Intuitive Machines’ IM-2 tipped over inside a south polar crater. What those back-to-back outcomes reveal about landing at the Moon’s edge.

The SEC’s October 2025 window for multiple Solana spot ETFs is the next big catalyst for crypto market structure. Here is how approve, deny, or conditional outcomes could ripple across flows, staking, DeFi, and the path for other altcoin ETFs.

Google is putting Gemini inside Chrome with AI Mode in the address bar, cross‑tab reasoning, and upcoming on‑page task automation. Here is what it means for SEO, ecommerce, privacy, and how to make your site agent‑readable now.

Workday’s Sana deal and new Agent System of Record mark a shift from scattered copilots to managed fleets of interoperable agents. Here is how governance, open protocols, and a data moat could reset enterprise AI middleware.

The U.S. Army’s Typhon launchers just appeared in Japan, putting Tomahawk and SM-6 back on land along the First Island Chain. Here is how the system’s loadout, kill-chain integration, mobility, and escalation risks reshape Indo-Pacific deterrence—and why Europe is next.

The DOE’s new Speed to Power push and Microsoft’s fresh Wisconsin build signal a scramble to keep firm capacity online as data centers surge. Here is how rules, costs, and resources are shifting from 2026 to 2030—and who wins or pays.

Retro Biosciences is set to begin first human testing in Australia of RTR242, an autophagy-activating pill aimed at Alzheimer’s. Paired with OpenAI’s GPT‑4b micro reprogramming work, it is a pivotal test for geroscience in the clinic.